Ruka hadi kwenye maudhui
Sasa

InaendeleaSiku ya 2

FDA's GLP-1 NAION warning order

  1. Taarifa mpya ya 1 kati ya 1Ya hivi karibuniSiku ya 2

    FDA orders GLP-1 eye-risk warnings: what the numbers mean

    The class-wide warning concerns rare, potentially permanent vision loss. The evidence warrants attention—not blanket advice to abandon treatment.

    Tazama

    U.S. Food and Drug Administration

    • 6.4Probable events per 100,000 person-years: GLP-1 treatment
    • 3.8Probable events per 100,000 person-years: comparison treatment
    • 15Probable events across both trial groups

Walioripoti

Walioripoti

17 vyombo vya habari · 24 vyanzo

12 kati ya 17 vilikuwa vimeripoti kufikia wakati huu

Nani aliripoti nini

Hoja zilizoripotiwa na zaidi ya chombo kimoja

Hoja zilizoripotiwa na chombo kimoja tu9

Imeripotiwa na Google News Kenya (KE:en) pekee

Imeripotiwa na The Independent pekee

Imeripotiwa na Google News México (MX:es-419) pekee

Kila mstari ni dai kama tulivyolirekodi kutoka kwenye ripoti ya chombo hicho. Imelinganishwa hadi .

Wanaohusika

Wanaohusika

Mashirika

  • United States Food and Drug Administrationagency of the US Department of Health and Human Services

Maeneo

  • United States